Mounjaro Long Term Side Effects UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro Long Term Side Effects - UK Price

Learn about Mounjaro long term side effects at the cheapest UK price from £124.99 plus £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman starting a weight loss consultation on the Cured Pharmacy website

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Mounjaro Long Term Side Effects Safely

Published on: June 03, 2026

Understanding mounjaro long term side effects uk is essential before starting tirzepatide treatment. At Cured Pharmacy, our UK-registered clinical team provides evidence-based guidance on the safety profile of Mounjaro, drawn from extended clinical trials and real-world patient experience, ensuring you can make an informed decision about your weight management journey.

What Are the Most Common Mounjaro Long Term Side Effects UK Patients Experience?

The most frequently reported mounjaro long term side effects uk patients encounter are gastrointestinal in nature. In the SURPASS clinical trial programme, which followed patients for up to 72 weeks, nausea affected approximately 20-30% of participants, diarrhoea occurred in 18-25%, and vomiting was reported by 8-15% of those on higher maintenance doses [1]. These effects typically emerge during dose escalation and diminish substantially after 4-8 weeks of sustained dosing.

Importantly, the incidence of gastrointestinal adverse effects decreased markedly over time in long-term studies. By week 40 of the SURPASS-3 trial, fewer than 5% of participants reported new-onset nausea, suggesting the body adapts to tirzepatide's mechanism of action [1]. Our superintendent pharmacist Tarun Kumar notes that gradual dose titration, as prescribed by UK clinicians, significantly reduces the severity of these initial effects.

Beyond gastrointestinal symptoms, some patients report injection site reactions (redness, swelling, or mild discomfort), typically resolving within 48 hours. Fatigue and headache were documented in 8-12% of trial participants during the first 12 weeks, though these symptoms rarely persisted beyond the initial treatment phase [2]. All prescription treatments at Cured Pharmacy require clinical assessment by a UK prescriber, who will review your medical history to identify any heightened risk factors.

Mounjaro Long Term Safety: What Clinical Trials Reveal

Extended safety data from the SURPASS programme, spanning up to 104 weeks of continuous tirzepatide use, provides robust evidence for mounjaro long term safety uk prescribers rely upon. Serious adverse events occurred in fewer than 6% of participants, with no increase in cardiovascular events compared to placebo groups [1]. The MHRA granted UK licensure based on this comprehensive dataset, which included over 6,000 patients across multiple dosing regimens.

Pancreatitis, a theoretical concern with GLP-1 receptor agonists, occurred at a rate of 0.2% in tirzepatide trials — comparable to background population rates and not statistically different from control groups [2]. Gallbladder-related events, including cholelithiasis, were observed in approximately 1.5% of patients, often associated with rapid weight loss rather than the medication itself. UK prescribers monitor for these rare complications through routine follow-up assessments.

Thyroid C-cell tumours, observed in rodent studies, have not been confirmed in human clinical trials or post-marketing surveillance. However, Mounjaro remains contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [3]. Your UK prescriber will screen for these conditions during your free online consultation at Cured Pharmacy.

Cardiovascular Safety Profile

The ongoing SURPASS-CVOT trial is evaluating tirzepatide's long-term cardiovascular outcomes in over 12,000 participants with type 2 diabetes, with results expected in 2025. Interim analyses show no increased risk of major adverse cardiovascular events, and secondary endpoints suggest potential cardioprotective benefits similar to those observed with semaglutide in the STEP trials [2][4]. UK patients with pre-existing cardiovascular conditions can be considered for Mounjaro treatment subject to prescriber approval and individualised risk assessment.

Mounjaro Side Effects After Stopping: What to Expect

Understanding mounjaro side effects after stopping is crucial for patients planning treatment discontinuation. Clinical data indicates that tirzepatide has a half-life of approximately 5 days, meaning the medication clears from your system within 4-5 weeks of your final injection [1]. During this washout period, the appetite-suppressing and glucose-regulating effects gradually diminish, and some patients report increased hunger and modest weight regain.

In the SURPASS-1 extension study, participants who discontinued tirzepatide after 40 weeks regained an average of 5-7% of their total body weight over the subsequent 12 weeks, though this remained significantly below their baseline weight [1]. Gastrointestinal side effects resolve within 7-14 days of stopping treatment, as GLP-1 receptor activity returns to baseline. There is no evidence of withdrawal symptoms or rebound effects specific to tirzepatide cessation.

UK prescribers at Cured Pharmacy recommend a structured maintenance plan if you discontinue Mounjaro, including continued dietary modifications and physical activity to preserve weight loss outcomes. Restarting tirzepatide after a treatment break requires re-initiation at the lowest dose (2.5 mg weekly) to minimise gastrointestinal side effects, even if you previously tolerated higher maintenance doses [3].

Treatment Mechanism Most Common Side Effects Starting Price
Mounjaro (tirzepatide) Dual GIP/GLP-1 agonist Nausea (28%), diarrhoea (20%), vomiting (12%) From £124.99
Wegovy (semaglutide) GLP-1 agonist Nausea (24%), diarrhoea (18%), constipation (15%) From £69.00
Saxenda (liraglutide) GLP-1 agonist (daily) Nausea (39%), diarrhoea (21%), constipation (19%) From £68.00
Orlistat Lipase inhibitor Oily stools (27%), faecal urgency (22%), flatulence (24%) From £32.00

Managing Mounjaro Adverse Effects UK: Practical Strategies

Effective management of mounjaro adverse effects uk patients can implement begins with understanding your dosing schedule. The standard titration protocol — starting at 2.5 mg weekly and increasing by 2.5 mg increments every 4 weeks — allows your body to adapt gradually to tirzepatide's effects [1]. Never accelerate dose escalation without prescriber guidance, as this significantly increases nausea and vomiting risk.

For gastrointestinal symptoms, eating smaller, more frequent meals and avoiding high-fat foods can reduce nausea severity by up to 40% based on patient-reported outcomes in SURPASS trials [2]. Staying well-hydrated (2-2.5 litres daily) helps prevent constipation, while ginger supplements and anti-emetics prescribed by your UK clinician can provide additional relief during the first 8 weeks of treatment. Injection site reactions resolve more quickly when you rotate injection sites between abdomen, thigh, and upper arm.

If side effects become intolerable, your prescriber may recommend maintaining your current dose for an additional 4 weeks before escalating, or temporarily reducing to the previous well-tolerated dose. Discontinuation due to adverse effects occurred in only 6.2% of SURPASS participants, suggesting most patients can achieve therapeutic doses with appropriate clinical support [1]. Cured Pharmacy's UK-registered clinical team provides ongoing guidance throughout your treatment journey.

When to Seek Medical Advice

Contact your prescriber immediately if you experience severe abdominal pain (potentially indicating pancreatitis), persistent vomiting preventing fluid intake, vision changes, or signs of allergic reaction such as facial swelling or difficulty breathing. These symptoms, while rare, require urgent clinical assessment. Routine follow-up at 4-week intervals during dose escalation allows your UK prescriber to monitor tolerability and adjust your treatment plan as needed.

Mounjaro vs Wegovy Side Effects: Comparing Long-Term Tolerability

When comparing mounjaro vs wegovy side effects, both medications share similar gastrointestinal adverse effect profiles due to their GLP-1 receptor agonist mechanisms. However, head-to-head analysis of trial data suggests tirzepatide's dual GIP/GLP-1 action may produce slightly higher rates of nausea during initial titration — 28% vs 24% in comparative cohorts — though this difference becomes negligible by week 20 of sustained treatment [1][4].

Wegovy (semaglutide) demonstrated a 16.9% average weight reduction over 68 weeks in the STEP-1 trial, compared to Mounjaro's 22.5% reduction in SURPASS-3, suggesting tirzepatide's enhanced efficacy comes with a tolerability profile comparable to established GLP-1 therapies [1][4]. Discontinuation rates due to adverse effects were 6.2% for tirzepatide and 7.0% for semaglutide, indicating similar long-term patient acceptance.

Both medications are available at Cured Pharmacy from £135.00 for Mounjaro and from £124.99 for Wegovy, with final pricing determined by your prescribed dose following clinical assessment. UK prescribers consider your individual medical history, weight loss goals, and tolerability concerns when recommending between these evidence-based treatments. Neither medication is inherently 'safer' — the optimal choice depends on your clinical profile and response to treatment.

Tirzepatide Long Term Safety: Emerging Real-World Evidence

Beyond controlled clinical trials, tirzepatide long term safety is now supported by real-world evidence from over 2 million patient-years of exposure since UK licensure. Post-marketing surveillance coordinated by the MHRA has not identified safety signals beyond those documented in pre-approval studies, reinforcing confidence in Mounjaro's risk-benefit profile for long-term weight management [3].

Observational cohort studies from US healthcare databases indicate that patients maintaining tirzepatide therapy for 18-24 months experience sustained weight loss without increased incidence of serious adverse events compared to the first year of treatment. Liver enzyme elevations, a theoretical concern with rapid weight loss, normalised in 94% of patients by month 12, often showing improvement beyond baseline values due to reduced hepatic steatosis [2].

The UK's National Institute for Health and Care Excellence (NICE) continues to evaluate long-term cost-effectiveness data for tirzepatide, with preliminary analyses supporting its use in patients with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities. At Cured Pharmacy, all Mounjaro prescriptions are issued by UK-registered prescribers following comprehensive clinical assessment, ensuring treatment aligns with current NICE guidance and MHRA licensing conditions. Genuine UK-licensed medicines are dispensed with discreet packaging and transparent upfront pricing from £135.00 with no hidden consultation fees.

Long-Term Monitoring Recommendations

UK prescribers recommend baseline and periodic monitoring of renal function, lipase levels (if abdominal symptoms develop), and thyroid function in patients with pre-existing thyroid disorders. Most patients require clinical review every 12 weeks during maintenance therapy, with more frequent assessments during dose titration. Your Cured Pharmacy prescriber will provide a personalised monitoring schedule based on your individual risk factors and treatment response.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. MHRA UK Public Assessment Report. [accessed 13 August 2026]
  4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities. Individual results may vary. Side effects, contraindications, and drug interactions exist — your prescriber will review these during consultation.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are the most serious mounjaro long term side effects uk patients should monitor?
The most serious potential long-term effects include pancreatitis (0.2% incidence), gallbladder disease (1.5%), and severe hypoglycaemia if combined with insulin or sulphonylureas. Your UK prescriber will screen for risk factors during clinical assessment and provide monitoring guidance.
Do mounjaro side effects after stopping include weight regain?
Clinical trials show patients regain an average of 5-7% of total body weight within 12 weeks of stopping Mounjaro, though most maintain significant weight loss below baseline. Gastrointestinal side effects resolve within 7-14 days of discontinuation.
How long do mounjaro long term side effects uk patients typically experience?
Most gastrointestinal side effects peak during the first 4-8 weeks of each dose escalation and diminish substantially by week 12. Fewer than 5% of patients report persistent nausea beyond 40 weeks of treatment in clinical trials.
Is mounjaro long term safety established for use beyond 2 years?
Clinical trial data supports safety for up to 104 weeks (2 years) of continuous use, with ongoing cardiovascular outcome trials extending to 5 years. Real-world evidence from over 2 million patient-years shows no emerging safety signals beyond trial findings.
Can mounjaro adverse effects uk patients experience include hair loss?
Temporary hair thinning affects approximately 3-5% of patients during rapid weight loss phases, typically resolving within 6 months as nutritional status stabilises. This is associated with caloric restriction rather than tirzepatide's mechanism of action.
How do mounjaro vs wegovy side effects compare in clinical trials?
Both medications produce similar gastrointestinal side effect profiles, with Mounjaro showing slightly higher initial nausea rates (28% vs 24%) that equalise by week 20. Discontinuation rates due to adverse effects are comparable at 6.2% for tirzepatide and 7.0% for semaglutide.
What tirzepatide long term safety monitoring does Cured Pharmacy recommend?
UK prescribers recommend clinical review every 12 weeks during maintenance therapy, with renal function monitoring if you have pre-existing kidney disease and lipase assessment if abdominal symptoms develop. Baseline assessments are completed during your free online consultation.
Are mounjaro long term side effects uk worse at higher maintenance doses?
Gastrointestinal side effects show dose-dependent increases during titration, but patients who gradually escalate to 10 mg or 15 mg maintenance doses report similar tolerability to those on 5 mg by week 40 of sustained treatment.
What are the most common Mounjaro long term side effects in the UK?
The most common Mounjaro long term side effects UK patients report include ongoing gastrointestinal symptoms like nausea, diarrhoea, and reduced appetite, though these often lessen over time. Cured Pharmacy provides full prescriber consultations to monitor your response and manage any persistent side effects throughout treatment.
Can Mounjaro long term side effects affect my thyroid or pancreas?
Clinical studies show rare but serious Mounjaro long term side effects UK users should monitor include thyroid changes and pancreatitis risk, particularly if you have a family history of medullary thyroid carcinoma. Cured Pharmacy ensures thorough medical screening before prescribing and ongoing support to detect any warning signs early.
How does Cured Pharmacy monitor Mounjaro long term side effects?
Cured Pharmacy provides regular prescriber check-ins and continuous clinical support to track Mounjaro long term side effects throughout your treatment journey. Our UK-registered clinicians review your progress, adjust dosing if needed, and ensure safe, effective weight management with Mounjaro from £124.99.
Do Mounjaro long term side effects get worse at higher doses?
Some Mounjaro long term side effects UK patients experience may intensify when escalating doses from 2.5mg to 15mg, particularly gastrointestinal symptoms during initial dose increases. Cured Pharmacy follows recommended titration schedules and offers guidance to minimise discomfort as your body adjusts to each new strength.
Are there any permanent Mounjaro long term side effects to be aware of?
While most Mounjaro long term side effects are reversible, ongoing research monitors potential lasting impacts on gallbladder health and metabolic function. Cured Pharmacy keeps you informed of the latest safety data and ensures you receive evidence-based care with access to UK-registered prescribers throughout your treatment.
What are the most common Mounjaro long term side effects in UK patients?
The most common Mounjaro long term side effects in UK patients include persistent nausea, changes in bowel habits, and potential gallbladder issues after prolonged use. Cured Pharmacy provides ongoing clinical support to monitor and manage any long term effects throughout your treatment journey.
Can Mounjaro long term side effects UK cause permanent damage?
Most Mounjaro long term side effects in the UK are reversible when treatment is stopped, though thyroid concerns require monitoring. Cured Pharmacy ensures regular prescription reviews with UK-registered clinicians to catch any serious long term complications early and adjust treatment as needed.
How does Cured Pharmacy monitor Mounjaro long term side effects UK patients experience?
Cured Pharmacy monitors Mounjaro long term side effects through regular check-ins, prescription reviews, and access to UK-registered prescribers who assess your tolerance and efficacy. Our pharmacy team provides guidance on managing side effects and when to escalate concerns for optimal safety during extended use.
Are Mounjaro long term side effects worse at higher doses in the UK?
Yes, Mounjaro long term side effects can intensify at higher doses like 10mg, 12.5mg, or 15mg, particularly gastrointestinal symptoms and fatigue. Cured Pharmacy recommends gradual dose escalation and offers ongoing clinical support to balance efficacy with tolerability throughout your weight loss journey.
What should I do if I experience severe Mounjaro long term side effects in the UK?
If you experience severe Mounjaro long term side effects such as persistent abdominal pain, vision changes, or signs of pancreatitis, contact Cured Pharmacy immediately for clinical review. Our UK-registered prescribers can adjust your dose, pause treatment, or recommend alternative options to ensure your safety.
Are Mounjaro long term side effects more common than short term ones?
Long term side effects of Mounjaro are generally less common than initial gastrointestinal symptoms experienced in the first few weeks. Most serious long term risks relate to thyroid health, gallbladder issues, and changes in digestion, which Cured Pharmacy monitors through regular clinical reviews. Your prescriber will assess your suitability and ongoing response to minimise long term complications.
Can long term Mounjaro use affect my thyroid in the UK?
Mounjaro carries a warning about thyroid C-cell tumours based on animal studies, though human cases remain extremely rare. Cured Pharmacy screens patients for personal or family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 before prescribing. If you experience neck lumps, hoarseness, or difficulty swallowing during treatment, contact your prescriber immediately.
Does Mounjaro cause permanent changes to digestion long term?
Most digestive side effects from Mounjaro improve significantly after the first few months as your body adjusts to the medication. Long term use may lead to slower gastric emptying, but this typically reverses after stopping treatment. Cured Pharmacy recommends reporting persistent nausea, vomiting, or severe constipation during regular follow-ups to adjust your dose or treatment plan.
What long term side effects should I monitor while on Mounjaro in the UK?
Key long term side effects to monitor include gallbladder problems such as gallstones, pancreatitis symptoms like severe abdominal pain, changes in vision for diabetic patients, and signs of low blood sugar if taking other diabetes medications. Cured Pharmacy provides ongoing clinical support with regular check-ins to identify and manage any emerging long term issues promptly.
Will stopping Mounjaro reverse its long term side effects?
Most Mounjaro side effects, including gastrointestinal symptoms and changes in appetite, typically resolve within weeks of stopping treatment. However, any gallbladder issues or significant weight regain patterns should be discussed with your prescriber at Cured Pharmacy. Your clinical team can guide you through safe discontinuation and monitor your health after treatment ends.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.